BridgeMD
New treatment option for Human Papillomavirus (HPV) Infection
Official title Effect of Different HPV Education Methods on Vaccination Intention in Young Women
ClinicalTrials.gov ID: NCT07420556
What this study is testing
- What it's testing
- Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 24, women only. Healthy volunteers may be eligible.
You may be able to join if
- Participants must meet all of the following criteria to be included in the study:
- Aged 18-24 years,
- Residing in Afşin district, Kahramanmaraş province,
- Willing to voluntarily participate in the study,
- Literate and able to understand survey questions in Turkish,
You likely can't join if
- Participants will be excluded if they meet any of the following conditions:
- Under 18 or over 24 years of age,
- Have received the HPV vaccine or started the vaccine series,
- Have been diagnosed with HPV infection,
- Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test),
- Illiterate or unable to understand the study forms in Turkish,
See the full eligibility criteria
- Participants must meet all of the following criteria to be included in the study:
- Aged 18-24 years,
- Residing in Afşin district, Kahramanmaraş province,
- Willing to voluntarily participate in the study,
- Literate and able to understand survey questions in Turkish,
- Have not previously received the HPV vaccine,
- Agree to be available throughout the study period (pre-test, post-education test, and 1-month follow-up test),
- Young women without physical or cognitive impairments or serious health problems that would prevent participation in the study.
- Participants will be excluded if they meet any of the following conditions:
- Under 18 or over 24 years of age,
- Have received the HPV vaccine or started the vaccine series,
- Have been diagnosed with HPV infection,
- Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test),
- Illiterate or unable to understand the study forms in Turkish,
- Withdraw from the study or indicate unwillingness to continue participation,
- Have serious hearing, vision, or cognitive impairments that would prevent meaningful engagement in the educational sessions.
The study team makes the final eligibility decision.
Where it's taking place
- Kahramanmaraş, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 24 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kahramanmaraş, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.